Key | % Net Assets |
---|---|
AstraZeneca PLC | 1.9% |
Royal Dutch Shell PLC (CL B) | 1.8% |
GlaxoSmithKline PLC | 1.8% |
Centrica PLC | 1.6% |
Other | 92.9% |
Name | % Net Assets |
---|---|
AstraZeneca PLC | 1.9% |
Royal Dutch Shell PLC (CL B) | 1.8% |
GlaxoSmithKline PLC | 1.8% |
Centrica PLC | 1.6% |
Daily Mail & General Trust PLC | 1.5% |
RSA Insurance Group PLC | 1.5% |
British American Tobacco PLC | 1.5% |
VT Group PLC | 1.5% |
Babcock International Group PLC | 1.4% |
Smith & Nephew PLC | 1.3% |
No asset data available.
Date | 10-May-2024 |
---|---|
NAV | 189.00p |
Currency | GBP |
Change | 1.80p |
% | 0.96% |
YTD change | 8.00p |
YTD % | 4.42% |
Fund Inception | 31/12/2002 |
---|---|
Fund Manager | Tim Russell |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000000 |
Additional | £500,000 |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.11 |
You are here: research